Analysis of interleukin (IL)-1β and transforming growth factor (TGF)- β-induced signal transduction pathways in IL-2 and TGF-β secretion and proliferation in the thymoma cell line EL4.NOB-1

Scandinavian Journal of Immunology

Volumn 49, Issue 2, 1999, Pages 139-148

  Siese, Anette ^a   Jaros, P P ^a   Willig, A ^a  

^a UNIVERSITY OF OLDENBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APIGENIN; CHELERYTHRINE; CONCANAVALIN A; CYCLIC AMP DEPENDENT PROTEIN KINASE; ENZYME; ENZYME INHIBITOR; INTERLEUKIN 2; MEPACRINE; MITOGEN ACTIVATED PROTEIN KINASE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLINOSITOL; PHOSPHOLIPASE A2; PHOSPHOLIPASE C; PHYTOHEMAGGLUTININ; PROTEIN KINASE C; RECOMBINANT INTERLEUKIN 1BETA; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA; TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THYMOMA; TUMOR CELL LINE;

ANIMALS; ENZYME ACTIVATION; ENZYME INHIBITORS; INTERLEUKIN-1; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; PHYTOHEMAGGLUTININS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-FOS; SIGNAL TRANSDUCTION; THYMOMA; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0033008217     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1999.00477.x     Document Type: Article

References (69)

1. Sosroseno W, Herminajeng E. The immunomodulatory roles of transforming growth factor beta. Br J Biomed Sci 1995;52:142-8.
2. McCartney-Francis NL, Wahl SM. Transforming growth factor β: a matter of life and death. J Leucocyte Biol 1994;55:401-9.
3. Kulkarni AB, Ward JM, Yaswen L et al. Transforming growth factor-β1 null mice - an animal model for inflammatory disorders. Am J Pathol 1995;146:264-75.
4. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996;87:2095-147.
5. 1 autoinduction. J Biol Chem 1989;264:7041-5.
6. Kim S-J, Angel P, Lavayaris R et al. Autoinduction of transforming growth factor-β1 is mediated by the AP-1 complex. Mol Cell Biol 1990;10:1492-7.
7. 1 when independently expressed is a functional binding protein for the mature growth factor. Biochemistry 1990;29:6851-7.
8. Wakefield LM, Smith DM, Flanders KC, Sporn MB. Latent transforming growth factor-β from human platelets. J Biol Chem 1988;263:7646-54.
9. Yin W, Smiley E, Germiller J et al. Isolation of a novel latent transforming growth factor-β binding protein gene (LTBP-3). J Biol Chem 1995;270:10147-60.
10. Miyazono K, Hellman U, Wenstedt C, Heldin CH. Latent high molecular weight complex of transforming growth factor-β1. J Biol Chem 1988;263:6407-15.
11. Miyazono K, Olofsson A, Colosetti P, Heldin CH. The role of the latent TGF-β1-binding protein in the assembly and secretion of TGF-βl. EMBO J 1991;55:1091-101.
12. Flaumenhaft R, Abe M, Sato Y, Harpel J, Heldin CH, Rifkin DB. Role of the latent TGF-β1-binding protein in the activation of latent TGF-β by co-cultures of endothelial and smooth muscle cells. J Cell Biol 1993;120:995-1002.
13. Sato Y, Okada F, Abe M et al. The mechanism for the activation of latent TGF-β during co-culture of endothelial cells and smooth muscle cells: cell-type specific targeting of latent TGF-β to smooth muscle cells. J Cell Biol 1993;123:1249-54.
14. Grande JP. Role of transforming growth factor-β in tissue injury and wound repair. Proc Soc Exp Biol Med 1997;214:27-40.
15. Nunes I, Shapiro RL, Rifkin DB. Characterization of latent TGF-β by murine peritoneal macrophages. J Immunol 1995;155:1450-9.
16. Carcamo J, Zentella L, Massague J. Disruption of transforming growth factor-β signalling by a mutation that prevents transphosphorylation within the receptor complex. Mol Cell Biol 1995;15:1573-81.
17. Vivien D, Attisano L, Wrana JL, Massague J. Signalling activity of homologues and heterologues transforming growth factor-β receptor kinase complexes. J Biol Chem 1995;270:7134-41.
18. Ventura F, Doody J, Liu F, Wrana JL, Massague J. Reconstitution and transphosphorylation of TGF-β receptor complexes. EMBO J 1994;13:5581-9.
19. Kolodziejczyk SM, Hall BK. Signal transduction and TGF-β superfamily receptors. Biochem Cell Biol 1996;74:299-314.
20. Hartsough TM, Mulder KM. Transforming growth factor-β signalling in epithelial cells. Pharmacol Ther 1997;75:21-41.
21. Zubler RH, Erard F, Lees RK et al. Mutant EL4 thymoma cells polyclonally activate murine and human B cells via direct cell interaction. J Immunol 1985;134:3662-8.
22. 3U/ ml of interleukin-2. J Immunol Methods 1987;99:7-11.
23. Bird TA, Gearing AJH, Saklatvala J. Murine interleukin-1 receptor: differences in binding between fibroblasts and thymoma cells and evidence for a two chain model. FEBS Lett 1987;225:21-6.
24. Espevik T, Waage A, Faxvaag A, Shalaby MR. Regulation of interleukin-2 and interleukin-6 production from T-cells: involvement of interleukin-1β and transforming growth factor-β. Cell Immunol 1990;126:47-56.
25. Van den Eijden Raaijd AJM, Koornee AJM, Vanzoele EJ. A new method for high-yield purification of type-beta transforming growth factor from human platelets. Biochem Biophys Res Commun 1988;157:16-23.
26. Kehrl JH, Wakefield LM, Roberts AB et al. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Methods 1986;163:1037-50.
27. Bristol LA, Ruscetti FW, Brody DT, Durum SK. IL-1α induces expression of active transforming growth factor-β in nonproliferative T cells via a post-transcriptional mechanism. J Immunol 1990;145:4108-14.
28. 1) inhibits DNA synthesis of PWM-stimulated PBMC via suppression of IL-2 and IL-6 production. Cytokine 1994;6:382-8.
29. 2) secreted by cells in culture. J Cell Physiol 1989;138:79-86.
30. Hansen MB, Nielsen SE, Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth. J Immunol Methods 1989;119:203-10.
31. Laemmli UK. Cleavage of structural proteins during assembly of head of bacteriophage T4. Nature 1970;227:680-5.
32. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979;76:4350-4.
33. 1) receptor expression on resting and mitogen-activated T cells. J Cell Biochem 1989;39:489-500.
34. + T lymphocytes. Int Immunol 1994;6:631-8.
35. Herbert JM, Augereau JM, Gleye J, Maffrand JP. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 1990;172:993-9.
36. Chijiwa T, Mishima A, Hagiwara M et al. Inhibition of forskolininduced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase N-(2-(p-bromocinnamylamino) ethyl)-5-isoquinolinesulfonamide (H89), of PC12D pheochromocytoma cells. J Biol Chem 1990;265:5267-72.
37. Kuo ML, Yang NC. Reversion of v-H-ras-transformed NIH 3T3 cells by apigenin through inhibiting mitogen activated protein kinase and its downstream oncogenes. Biochem Biophys Res Commun 1995;212:767-75.
38. 2 activation and autoinduction of tumor necrosis factor gene expression and by tumor necrosis factor. Cancer Res 1990;50:7101-7.
39. Powis G, Seewald MJ, Gratas C, Melder D, Riebow J, Modest EJ. Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analouges. Cancer Res 1992;52:2835-40.
40. Schuetze S, Potthoff K, Machleidt T, Berkovic D, Wiegmann K, Kroenke M. TNF activates NFκB by phosphatidylcholine-specific phospholipase C-induced 'acid' sphingomyelin breakdown. Cell 1992;71:765-76.
41. Munoz E, Zubiaga AM, Sims JE, Huber BT. Two functional IL-1 receptors are expressed in T-cells. J Immunol 1991;146:136-43.
42. Akarasereenont P, Thiemermann C. The induction of cyclooxygenase-2 in human pulmonary epithelial cell culture (A549) activated by IL-1 is inhibited by tyrosine kinase inhibitors. Biochem Biophys Res Commun 1996;220:181-5.
43. Muegge K, Williams TM, Kant J et al. Interleukin-1 costimulatory activity on the interleukin-2 promoter via AP-1. Science 1989;246:249-51.
44. Stoeck M, Howe RC, Miescher S, von Flieder V, MacDonald HR. Effect of transforming growth factor beta on the EL4 thymoma variant EL4./6.1. Dissociation of inhibition of proliferation from IL-1 and IL-2 receptors. Immunobiology 1990;181:13-21.
45. Dubois CM, Ruscetti FW, Palaszynski EW, Falk LA, Oppenheim JJ, Keller JR. Transforming growth factor β is a potent inhibitor of interleukin-1 (IL-1) receptor expression. Proposed mechanism of inhibition of IL-1 action. J Exp Med 1990;172:737-47.
46. Zumbihl R, Dornard J, Fischer T et al. IL-1 stimulates a divering signaling pathway in EL4 6.1. thymoma cells. J Immunol 1995;155:181-9.
47. Macchia G, Baldari CT, Massone A, Telford JL. A role for PKC activity in interleukin-I (IL-1) induction of IL-2 gene expression but not in IL-1 signal transduction. Mol Cell Biol 1990;10:2731-7.
48. Falk W, Von Hoegen I, Krammer PH. Activation of T cells by interleukin 1 involves internalisation of interleukin 1. Lymphokine Res 1989;8:263-8.
49. Schuetze S, Machleidt T, Kroenke M. The role of diacylglycerol and ceramide in tumor necrosis factor and interleukin-1 signal transduction. J Leucocyte Biol 1994;56:533-41.
50. Carlson CD, Hart RP. Activation of acidic sphingomyelinase and protein kinase Cδ is required for IL-1 induction of LIF mRNA in a schwann cell line. Glia 1996;18:49-58.
51. Herrmann DBJ, Neumann HA. Cytotoxic ether lipids, J Biol Chem 1986;261:7742-7.
52. 1 positively regulates its own expression in normal and transformed cells. J Biol Chem 1988;263:7741-6.
53. 1 and its receptor by cyclosporine in human T lymphocytes. Transplantation 1995;60:718-23.
54. Takahama Y, Letterio JJ, Suzuki H, Farr AG, Singer A. Early progression of thymocytes along the CD4/CD8 developmental pathway is regulated by a subset of thymic epithelial cells expressing transforming growth factor β. J Exp Med 1994;179:1495-506.
55. 1 gene expression by glucocorticoids in normal human T-lymphocytes. J Clin Invest 1991;88:1574-80.
56. 1. Toxicol Appl Pharmacol 1994;126:98-107.
57. 1 inhibition of transin/ stromelysin gene expression is mediated through a fos binding sequence. Cell 1990;61:267-78.
58. Kanatani Y, Kasukabe T, Okabe-Kado J et al. Transforming growth factor-β and dexamethason cooperatively enhance c-jun gene expression and inhibit the growth of human monocytoid leukemia cells. Cell Growth Diff 1996;7:187-96.
59. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 1995;270:16483-6.
60. Guy RC, Philip R, Tan YH. Activation of protein kinases and the inactivation protein phosphatase 2A in tumor necrosis factor and interleukin-1 signal transduction pathways. Eur J Biochem 1995;229:503-11.
61. Appel A, Kracht M, Peterson K, Resch K, Szamel M. Interleukin-1 induced signalling. Biphasic activation of mitogen-activated protein kinase kinase and mitogen-activated protein kinases in HeLa cells. Involvement of phosphoprotein phosphatases. Eur Cytokine Netw 1996;7:775-84.
62. Scherle PA, Pratta MA, Freeser WS, Tancula EJ, Arner EC. The effects of IL-1 on mitogen-activated protein kinases in rabbit articular chondrocytes. Biochem Biophys Res Commun 1997;230:573-7.
63. Yu W, Sanders BG, Kline K. Modulation of murine EL4 thymic lymphoma cell proliferation and cytokine production by vitamin E succinate. Nutr Cancer 1996;25:137-49.
64. 1 precursor in the golgi complex in a latent endoglycosidase H-sensitive form. J Biol Chem 1992;267:5668-75.
65. Kozubik A, Hofmanova J, Dusek L. Eicosanoid inhibitors enhance synergistically the effect of transforming growth factor β1 on CCL64 cell proliferation. Eur J Pharmacol 1996;316:349-57.
66. Lowenthal JW, Cerottini J-C, MacDonald HR. Interleukin-1 dependent induction of both interleukin 2 secretion and interleukin 2 receptor expression by thymoma cells. J Immunol 1986;137:1226-31.
67. Stylianou E, O'Neil LAJ, Rawlinson L, Edbrooke MR, Woo P, Saklatvala J. Interleukin-1 induces NF-κB through its type I but not its type II receptor in lymphocytes. J Immunol 1992:267:15836-41.
68. Croston GE, Cao Z, Goeddel DV. NF-κB activation by interleukin-1 (IL-1) requires an IL-1 receptor-associated protein kinase activity. J Biol Chem 1995;270:16514-7.
69. Farrar WL, Humes JL. The role of arachidonic acid metabolism in the activities of interleukin 1 and interleukin 2. J Immunol 1985;135:1153-9.